Could a home device replace hospital stays for High-Risk pregnancies?

NCT ID NCT06859177

Recruiting now Knowledge-focused Sponsor: Maxima Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether pregnant women with complications like pre-eclampsia or fetal growth restriction can use a remote device at home to monitor their baby's heart rate. Sixty participants between 32 and 37 weeks of pregnancy will try the device daily. Researchers will check how often the measurements work and how satisfied patients and doctors are.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remote eCTG monitoring device (Nemo Remote®)
What this could lead to: If successful, this could allow some high-risk pregnant women to monitor their baby's heart rate from home instead of staying in the hospital.
What could go wrong: This is a small, early feasibility study with only 60 participants. The device may not work reliably for everyone, and it is not yet proven to improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEASIBILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction Personal Satisfaction preeclampsia pregnancy disorder preterm premature rupture of the membranes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEASIBILITY PREGNANCY RELATED REMOTE MONITORING

Contacts and locations

Locations

Maxima Medical Center
RECRUITING

Veldhoven, North Brabant, 5504DB, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.